Literature DB >> 2583224

Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture.

L M Villar1, G Roy, I Lázaro, J C Alvarez-Cermeno, M González, J A Brieva, M L Del la Sen, G Leoro, A Bootello, P González-Porqué.   

Abstract

Soluble major histocompatibility complex class I molecules (sHLA) present in human serum can be resolved by gel filtration into two different peaks with an apparent molecular mass of about 200 kDa (30% of the total) and 50-60 kDa (60%-70%). The serological analysis of the peaks shows that A or B specificities can only be detected in the 200 kDa peak while both are recognized by the monomorphic W6/32 monoclonal antibody (mAb) and anti-beta 2-microglobulin mAb. Such sHLA (non HLA-A or -B) molecules are released from human spleen membranes upon incubation at 37 degrees C and have been purified by affinity chromatography with mAb W6/32 bound to Sepharose. The molecular mass analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the sHLA (non HLA-A or -B) and of the classical HLA-A or -B antigens still bound to the membranes and purified from the same membranes after detergent solubilization does not show a significant difference, indicating that sHLA do not represent proteolytic fragments of the classical HLA-A or -B antigens. The presence of sHLA (non HLA-A or -B) has also been detected in the supernatants of lymphocyte cultures and increases dramatically upon stimulation by mitogens. The effect of pokeweed mitogen, phytohemagglutinin, Staphylococcus aureus Cowan strain and phorbol 12-myristate 13-acetate on the secretion of sHLA has been studied. The molecular mass of the secreted sHLA (detected using [14C]leucine) is compared with the classical transmembrane proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583224     DOI: 10.1002/eji.1830191012

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Measurement of HLA class I expression in ankylosing spondylitis.

Authors:  P Creamer; J Edmonds; J Sullivan; S Matthews
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery.

Authors:  A Ferreira; M C García Rodríguez; F Omeñaca; A Jiménez; L M Villar; P Gonzalez-Porqué; G Fontán
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  Soluble HLA class I antigens in sera of patients with chronic hepatitis.

Authors:  K Sakaguchi; N Koide; T Takenami; H Matsushima; H Takabatake; S Ferrone; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1992-04

4.  Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood.

Authors:  P Tabaczewski; H Shirwan; K Lewis; I Stroynowski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

5.  Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.

Authors:  J A Brieva; L M Villar; G Leoro; J C Alvarez-Cermeño; E Roldán; P Gonzalez-Porqué
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

6.  Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.

Authors:  S Mansueto; G Vitale; C Mocciaro; G Gambino; P Colletti; P Mansueto; A Spinelli; M Affronti; N Chifari; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  Detection in chick embryo of fetoproteins not recognized by the dam's immune system and of soluble alloantigens. Presumptive teratogenic and abortogenic capacity of their specific IgY.

Authors:  Antonio Rodríguez-Burgos
Journal:  BMC Immunol       Date:  2003-06-27       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.